# Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

> **NCT05757167** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 2174 (actual)

## Conditions studied

- Malaria,Falciparum
- Malaria in Pregnancy
- Malaria in Childbirth
- Pregnancy
- Neonatal Health
- Low Birthweight
- Stillbirth
- Gestational Age and Weight Conditions
- Preterm Birth

## Interventions

- **DIAGNOSTIC_TEST:** Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
- **DRUG:** Artemether-lumefantrine (AL)

## Key facts

- **NCT ID:** NCT05757167
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 2174 (ACTUAL)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757167, "Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT05757167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*